Development of Two Mouse Models for Vaccine Evaluation against Cryptosporidiosis

Infect Immun. 2022 Jul 21;90(7):e0012722. doi: 10.1128/iai.00127-22. Epub 2022 Jun 23.

Abstract

Cryptosporidiosis was shown a decade ago to be a major contributor to morbidity and mortality of diarrheal disease in children in low-income countries. A serious obstacle to develop and evaluate immunogens and vaccines to control this disease is the lack of well-characterized immunocompetent rodent models. Here, we optimized and compared two mouse models for the evaluation of vaccines: the Cryptosporidium tyzzeri model, which is convenient for screening large numbers of potential mixtures of immunogens, and the Cryptosporidium parvum-infected mouse pretreated with interferon gamma-neutralizing monoclonal antibody.

Keywords: Cryptosporidiosis; Cryptosporidium parvum; Cryptosporidium tyzzeri; animal models; interferon gamma; vaccine evaluation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cryptosporidiosis* / prevention & control
  • Cryptosporidium parvum*
  • Cryptosporidium*
  • Diarrhea
  • Disease Models, Animal
  • Mice